Ocular Therapeutix Commercial Paper Liability (Quarterly) Insights

Ocular Therapeutix, Inc. (OCUL)

8.955 +0.54 (+6.48%) USD | NASDAQ | Feb 24, 16:00

9.05 +0.10 (+1.06%) After-Hours: 07:23

View Commercial Paper Liability (Quarterly) for OCUL.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Commercial Paper Liability (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Commercial Paper Liability (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Commercial Paper Liability (Quarterly) Benchmarks

Start Trial

Regeneron Pharmaceuticals, Inc.	--
Boston Scientific Corp.	--
Alnylam Pharmaceuticals, Inc.	--
EyePoint Plc	--
Vertex Pharmaceuticals, Inc.	--